Drug Discovery World

NOVEMBER 18, 2022

The annual Genesis conference will take place on 7 December 2022 in London, and 5,6 and 8 December online, bringing key opinion leaders, investors and innovators from across the life sciences sector under one roof to exchange insights, debate trends and generate deals.

Life Science 52

Life Science Big Data Drugs Clinical Trials 52

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. There will be greater emphasis on diversity in clinical trials. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. .

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

XTalks

MAY 9, 2024

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

Drug Discovery World

OCTOBER 12, 2022

DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. . Companies are using sensors that we can put on our wrist or chest and capture all types of data.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Sales 52

pharmaphorum

OCTOBER 16, 2020

By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs. For instance, provided a drug has not failed a trial on safety, the side effects it caused in one population could constitute on-target effects in another.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Life Science 101

The Pharma Data

JULY 12, 2021

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. HUMANOID Center of Research Excellence?(CoRE), biotech companies?have

Drugs 52

Drugs Gene Expression Big Data Gene 52

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Universities are also using these digital technologies to advance their research. The company’s platform evaluated more than 11.4

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

FEBRUARY 11, 2022

Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of rare diseases by providing CZI’s Rare as One Network healthcare data and software. About the author.

Life Science 101

Life Science Engineer Development Big Data 101

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

pharmaphorum

MAY 25, 2021

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. But, until recently, an important data source has been locked up in the electronic health record (EHR), often in the form of unstructured or ‘free’ text entered by healthcare professionals.

Big Data 134

Big Data Clinical Research Research Trials 134

Drug Discovery World

SEPTEMBER 6, 2022

And whilst clinical trials activity decreased by around 15% compared to 2020, last year still saw a number of regenerative medicines reach the bedside. As is always the case with pharmaceuticals, the industry’s capabilities to manufacture and produce these potentially life-saving therapies will be of concern. .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

pharmaphorum

SEPTEMBER 18, 2020

“AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Following AstraZeneca’s creation, the pharma company began to focus on five main areas of research – cardiovascular, gastrointestinal, respiratory, oncology and local and general anaesthesia.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. billion ($3.65 billion ($2.85

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 115

Doctors Doctor Life Science Clinical Research 115

Pharmaceutical Technology

JUNE 20, 2023

The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms. Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? In clinical trials, the use of plain language for participants is essential.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130